Fetal and neonatal alloimmune thrombocytopenia: A rare case report of prenatal treatment

被引：2
|
作者：
Giouleka, Sonia [1 ]
Tsakiridis, Ioannis [1 ]
Zachomitros, Fotios [1 ]
Mamopoulos, Apostolos [1 ]
Kalogiannidis, Ioannis [1 ]
Athanasiadis, Apostolos [1 ]
Dagklis, Themistoklis [1 ]
机构：
[1] Aristotle Univ Thessaloniki, Fac Hlth Sci, Sch Med, Dept Obstet & Gynecol 3, Konstantinoupoleos 49, Thessaloniki 54642, Greece
来源：
CLINICAL CASE REPORTS | 2023年 / 11卷 / 08期
关键词：
alloimmune thrombocytopenia; diagnosis; management; outcome; pregnancy; ANTENATAL MANAGEMENT; COST-EFFECTIVENESS; RISK; DIAGNOSIS; THERAPY;
D O I：
10.1002/ccr3.7806
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Key Clinical MessageFetal and neonatal alloimmune thrombocytopenia (FNAIT) is a rare but serious condition. The first-line antenatal management of FNAIT consists of weekly IVIG with or without corticosteroids, ideally starting before 16 weeks of gestation.
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Fetal and neonatal alloimmune thrombocytopenia: prenatal interventions
    Kamphuis, Marije M.
    Oepkes, Dick
    PRENATAL DIAGNOSIS, 2011, 31 (07) : 712 - 719
  • [2] Fetal/neonatal alloimmune thrombocytopenia
    Sachs, Ulrich J.
    THROMBOSIS RESEARCH, 2013, 131 : S42 - S46
  • [3] New developments in fetal and neonatal alloimmune thrombocytopenia
    Bussel, James B.
    Vander Haar, Emilie L.
    Berkowitz, Richard L.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 225 (02) : 120 - 127
  • [4] Fetal and Neonatal Alloimmune Thrombocytopenia: Harvesting the Evidence to Develop a Clinical Approach to Management
    Symington, Amanda
    Paes, Bosco
    AMERICAN JOURNAL OF PERINATOLOGY, 2011, 28 (02) : 137 - 144
  • [5] Fetal and neonatal alloimmune thrombocytopenia
    Bertrand, G.
    Kaplan, C.
    IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2013, 28 (5-6): : 335 - 342
  • [6] New Horizons in Fetal and Neonatal Alloimmune Thrombocytopenia
    Barg, Assaf
    Bonstein, Lilach
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2023, 49 (04): : 402 - 408
  • [7] Fetal and neonatal Alloimmune Thrombocytopenia, Part 2 Risk Stratification and Treatment
    Sachs, Ulrich J.
    Bedei, Ivonne
    Wienzek-Lischka, Sandra
    Cooper, Nina
    Ehrhardt, Harald
    Axt-Fliedner, Roland
    Bein, Gregor
    TRANSFUSIONSMEDIZIN, 2021, 11 (02) : 127 - 142
  • [8] Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT) Scientific Impact Paper No. 61
    Regan, F.
    Lees, C. C.
    Jones, B.
    Nicolaides, K. H.
    Wimalasundera, R. C.
    Mijovic, A.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2019, 126 (10) : E173 - E185
  • [9] Clinical and laboratory predictors of fetal and neonatal alloimmune thrombocytopenia
    Matusiak, Kristine
    Patriquin, Christopher J.
    Deniz, Stacy
    Dzaja, Nancy
    Smith, James W.
    Wang, Grace
    Nazy, Ishac
    Kelton, John G.
    Arnold, Donald M.
    TRANSFUSION, 2022, 62 (11) : 2213 - 2222
  • [10] Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach
    Lieberm, Lani
    Greinacher, Andreas
    Murphy, Michael F.
    Bussel, James
    Bakchoul, Tamara
    Corke, Stacy
    Kjae, Mette
    Kjeldsen-Kragh, Jens
    Bertrand, Gerald
    Oepkes, Dick
    Bake, Jillian M.
    Hum, Heather
    Masse, Edwin
    Kapla, Cecile
    Arnold, Donald M.
    Baidya, Shoma
    Ryan, Greg
    Savoia, Helen
    Landry, Denise
    Shehata, Nadine
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (03) : 549 - 562
12345